IGI Logo

Lupin is currently trading at Rs. 1136.30, up by 23.35 points or 2.10% from its previous closing of Rs. 1112.95 on the BSE.

The scrip opened at Rs. 1129.95 and has touched a high and low of Rs. 1143.70 and Rs. 1123.95 respectively. So far 20646 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1,143.70 on 17-Aug-2023 and a 52 week low of Rs. 623.20 on 19-Sep-2022.

Last one week high and low of the scrip stood at Rs. 1143.70 and Rs. 1073.65 respectively. The current market cap of the company is Rs. 50649.93 crore.

The promoters holding in the company stood at 47.07%, while Institutions and Non-Institutions held 43.30% and 9.64% respectively.

Lupin has launched Jeet, its patient support program dedicated to heart-health. The initiative launch coincides with India’s 76th Independence Day, symbolizing freedom from disease-related stress and a journey towards a happier and healthier life. Jeet will be a trusted partner in cardiovascular care, offering a range of benefits including savings on medical costs, disease counselling, medication reminders and lifestyle support.

Jeet can be accessible through the Play or App Store, as well as the website https://lupinjeet.com. Jeet offers a comprehensive approach to enhancing the doctor-patient experience by raising awareness about cardiovascular ailments and associated co-morbid conditions. The program includes features designed to encourage healthier lifestyle choices and provides support and care for a healthy heart. Jeet ensures timely medication reminders and promotes daily health and wellness activities including interactions that resonate with patients.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.